home · filing · 0000950170-22-005307
8-K filed April 4, 2022, 7:59 PM ET
ticker RLYB
CIK 0001739410
leadership
confidence high
sentiment neutral
materiality 0.40
Rallybio appoints Christine Nash and Hui Liu to board; Shannon to resign at annual meeting
Rallybio Corp
Board size increased from 8 to 10; Christine Nash and Hui Liu appointed as directors effective April 4, 2022.
Nash appointed to Compensation Committee; Liu appointed to Audit Committee.
Director Timothy Shannon to resign at Rallybio's 2022 annual meeting of shareholders.
Nash brings rare disease commercial/product launch experience; Liu brings business development and finance expertise.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Hui Liu
Director
Effective 2022-04-04
Filed April 4, 2022, 7:59 PM ET
appointed Christine A. Nash and Hui Liu, Ph.D., each to serve as a director to fill the newly created vacancies, effective April 4, 2022.
Appointed
Christine A. Nash
Director
Effective 2022-04-04
Filed April 4, 2022, 7:59 PM ET
appointed Christine A. Nash and Hui Liu, Ph.D., each to serve as a director to fill the newly created vacancies, effective April 4, 2022.
Departed
Timothy Shannon
Director
Filed April 4, 2022, 7:59 PM ET
Timothy Shannon notified Rallybio that he would resign from the Board, effective at Rallybio’s 2022 annual meeting of shareholders.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Hui Liu was appointed as Director at Rallybio Corp.
Action appointed
Role Director
Exact text from the filing
appointed Christine A. Nash and Hui Liu, Ph.D., each to serve as a director to fill the newly created vacancies, effective April 4, 2022.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Christine A. Nash was appointed as Director at Rallybio Corp.
Action appointed
Role Director
Exact text from the filing
appointed Christine A. Nash and Hui Liu, Ph.D., each to serve as a director to fill the newly created vacancies, effective April 4, 2022.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Timothy Shannon resigned as Director at Rallybio Corp.
Action resigned
Role Director
Exact text from the filing
Timothy Shannon notified Rallybio that he would resign from the Board, effective at Rallybio’s 2022 annual meeting of shareholders.
View on SEC.gov
Source: SEC EDGAR
accession 0000950170-22-005307
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.